menu search

GDBYF / Goodbody Health launches health 'MOT' to test for diabetes and cholesterol risk

Goodbody Health launches health 'MOT' to test for diabetes and cholesterol risk
Goodbody Health Inc (AQSE:GBDY, CSE:GBDY, OTC:SCNNF) said it is launching a health ‘MOT' test to be offered at its UK high street stores and via pharmacies, where customers will get results of diabetes and cholesterol tests “in minutes”. Priced at £99, the company said the innovative tests determine a person's risk for developing cardiac health problems or diabetes over the next 10 years. Read More
Posted: May 26 2022, 02:41
Author Name: Proactive Investors
Views: 111535

GDBYF News  

Goodbody Health makes strategic strides

By Proactive Investors
April 21, 2023

Goodbody Health makes strategic strides

Goodbody Health Ltd (AQSE:GDBY) said its 2022 results reflect its successful diversification as it added a wider range of diagnostic tests and began t more_horizontal

Goodbody Health launches mobile blood testing service

By Proactive Investors
March 16, 2023

Goodbody Health launches mobile blood testing service

Goodbody Health has launched its new mobile phlebotomy service to “develop and increase” the reach of phlebotomy testing. Phlebotomy is a procedur more_horizontal

Goodbody Health extends phlebotomy services with contract win

By Proactive Investors
February 15, 2023

Goodbody Health extends phlebotomy services with contract win

Goodbody Health signed a contract with blood testing company Thriva as it continues to make progress on extending its phlebotomy services. A phlebotom more_horizontal

Goodbody Health to offer multi-cancer screening services via liquid biopsy test

By Proactive Investors
January 26, 2023

Goodbody Health to offer multi-cancer screening services via liquid biopsy test

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) said its network of UK clinics will start offering multi-cancer screening service, as part of a partnersh more_horizontal

Goodbody Health reports boardroom changes

By Proactive Investors
December 30, 2022

Goodbody Health reports boardroom changes

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) has announced that its chair Geremy Thomas will be stepping down from his executive duties, effective 1st more_horizontal

Goodbody Health sells Polish CBD facility

By Proactive Investors
December 16, 2022

Goodbody Health sells Polish CBD facility

Goodbody Health has agreed to sell its Polish CBD-related operations to Voyager Life for £1.5mln, comprising £0.5m cash and £1mln of convertible lo more_horizontal

Goodbody Health announces appointment of George Thomas as its chief executive officer with immediate effect

By Proactive Investors
December 1, 2022

Goodbody Health announces appointment of George Thomas as its chief executive officer with immediate effect

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) has announced that George Thomas, an existing executive director of the company and managing director of more_horizontal

Goodbody Health turns focus to preventative diagnostics

By Proactive Investors
November 11, 2022

Goodbody Health turns focus to preventative diagnostics

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) said its focus is now on preventative diagnostics as it looks to become a “leading aggregator” of inn more_horizontal


Search within

Pages Search Results: